Sherman L - Search Results

1

A splice variant of CD44 expressed in the rat apical ectodermal ridge contributes to limb outgrowth.

Wainwright D, Sherman L, Sleeman J, Ponta H, Herrlich P. Wainwright D, et al. Among authors: sherman l. Ann N Y Acad Sci. 1996 Jun 8;785:345-9. doi: 10.1111/j.1749-6632.1996.tb56305.x. Ann N Y Acad Sci. 1996. PMID: 8702177 No abstract available.

2

The role of CD44 splice variants in human metastatic cancer.

Sleeman J, Moll J, Sherman L, Dall P, Pals ST, Ponta H, Herrlich P. Sleeman J, et al. Among authors: sherman l. Ciba Found Symp. 1995;189:142-51; discussion 151-6, 174-6. doi: 10.1002/9780470514719.ch11. Ciba Found Symp. 1995. PMID: 7587629 Review.

3

Schwann cell tumors express characteristic patterns of CD44 splice variants.

Sherman L, Skroch-Angel P, Moll J, Schwechheimer K, Ponta H, Herrlich P, Hofmann M. Sherman L, et al. J Neurooncol. 1995 Dec;26(3):171-84. doi: 10.1007/BF01052620. J Neurooncol. 1995. PMID: 8750183 Review.

4

The CD44 proteins in embryonic development and in cancer.

Sherman L, Sleeman J, Dall P, Hekele A, Moll J, Ponta H, Herrlich P. Sherman L, et al. Curr Top Microbiol Immunol. 1996;213 ( Pt 1):249-69. doi: 10.1007/978-3-642-61107-0_15. Curr Top Microbiol Immunol. 1996. PMID: 8814991 Review. No abstract available.

5

A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth.

Sherman L, Wainwright D, Ponta H, Herrlich P. Sherman L, et al. Genes Dev. 1998 Apr 1;12(7):1058-71. doi: 10.1101/gad.12.7.1058. Genes Dev. 1998. PMID: 9531542 Free PMC article.

6

How tumor cells make use of CD44.

Herrlich P, Sleeman J, Wainwright D, König H, Sherman L, Hilberg F, Ponta H. Herrlich P, et al. Among authors: sherman l. Cell Adhes Commun. 1998;6(2-3):141-7. doi: 10.3109/15419069809004470. Cell Adhes Commun. 1998. PMID: 9823465 Review.

7

Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.

Sleeman JP, Arming S, Moll JF, Hekele A, Rudy W, Sherman LS, Kreil G, Ponta H, Herrlich P. Sleeman JP, et al. Among authors: sherman ls. Cancer Res. 1996 Jul 1;56(13):3134-41. Cancer Res. 1996. PMID: 8674073

8

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA, Gutmann DH, Ponta H, Herrlich P. Morrison H, et al. Among authors: sherman ls. Genes Dev. 2001 Apr 15;15(8):968-80. doi: 10.1101/gad.189601. Genes Dev. 2001. PMID: 11316791 Free PMC article.

9

CD44: from adhesion molecules to signalling regulators.

Ponta H, Sherman L, Herrlich PA. Ponta H, et al. Among authors: sherman l. Nat Rev Mol Cell Biol. 2003 Jan;4(1):33-45. doi: 10.1038/nrm1004. Nat Rev Mol Cell Biol. 2003. PMID: 12511867 Review.

10

Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression.

Sherman L, Sleeman J, Herrlich P, Ponta H. Sherman L, et al. Curr Opin Cell Biol. 1994 Oct;6(5):726-33. doi: 10.1016/0955-0674(94)90100-7. Curr Opin Cell Biol. 1994. PMID: 7530464 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

921 results

Search Page